跳至主要内容
临床试验/TCTR20180425001
TCTR20180425001已完成未知

Evaluation of the benefit of supplementation with alpha-tocopherol and ascorbic acid to non-alcoholic fatty liver disease’s statin therapy in men - Randomized Controlled Trial.

Ss. Cyril and Methodius University in Skopje0 个研究点目标入组 74 人开始时间: 2018年4月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 Years 至 60 Years(—)
性别
Male

入选标准

  • Patients were required to have hepatorenal contrast and liver brightness according to the scoring system by doi:10.1111/j.1572-0241.2007.01526.x

排除标准

  • Patients were excluded if they had any other chronic liver disease, malignancy or inflammatory disease.

研究者

发起方
Ss. Cyril and Methodius University in Skopje

相似试验

Supplementation with alpha-tocopherol and... | 临床试验